Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study

by Leonardo De Luca, Lucio Gonzini, Stefano Urbinati, Adriano Murrone, Fortunato Scotto di Uccio, Fabio Ferrari, Fabiana Lucà, Donata Lucci, Domenico Gabrielli, Andrea Di Lenarda, Michele Massimo Gulizia
Published 2020-12-01

Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study.

by Leonardo De Luca, Pier Luigi Temporelli, Donata Lucci, Furio Colivicchi, Paolo Calabrò, Carmine Riccio, Antonio Amico, Franco Mascia, Emanuele Proia, Andrea Di Lenarda, Michele Massimo Gulizia, START Investigators
Published 2018-01-01

Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?

by Leonardo Bolognese, Andrea Rubboli, Leonardo De Luca, Donata Lucci, Domenico Gabrielli, Andrea Di Lenarda, Michele Massimo Gulizia, Massimo Uguccioni, Simonetta Blengino, Jeness Campodonico, Ilaria Meynet, Silvia Maria Brach Prever
Published 2021-08-01

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

by Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators
Published 2016-02-01